Nestle Health Science is investing $41 million private equity into biopharmaceutical company Enterome to research and develop drugs treating inflammatory bowel disease and food allergies. Enterome ...
TipRanks on MSN
Shake Shack reports Q3 adjusted EPS 36c, consensus 31c
Reports Q3 revenue $367.41M, consensus $363.71M. Reports Q3 same-Shack sales up 4.9%. The company said, “Opened 13 new Company-operated Shacks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback